23andMe

Biotech

23andMe Stock Crashes After Bankruptcy Filing—What Happens to Users’ Genetic Data Now?

Shares of 23andMe (NASDAQ: ME) imploded this week after the embattled genetic testing company filed for Chapter 11 bankruptcy and…

Read More »
Back to top button